PeriodontitisPhase 1NCT03754010
Does Hyaluronic Acid Affect Periodontal Treatment?
A Phase 1 study testing Scaling and root planning, Hyaluronic acid gel (HA) and SRP and HA mouthrinse and SRP in people with Periodontitis, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).
Trial summary
Objective: The aim of this study is to evaluate the effect of HA as an adjunct to scaling and root planning (SRP) on clinical parameters, periodontal inflamed surface area (PISA) and adenosine deaminase (ADA), catalase (CAT), and glutathione (GSH) levels in gingival crevicular fluid (GCF) in patients with… Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Periodontitis
- What is being tested?
- Scaling and root planning, Hyaluronic acid gel (HA) and SRP and HA mouthrinse and SRP
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 24 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Aug 2017to 30 Sep 2018
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Systemically healthy
- moderate-to-severe periodontitis
- at least five sites with ≥5mm probing depth (PD)
- at least ≥20 teeth
- Stage II-III periodontitis according to the 2017 World Workshop
- Age between18-55
Who cannot join
- receiving systemic or local antibiotics within the past six months
- prior surgical or non-surgical periodontal treatment within the past six months
- smoking
- pregnancy
- lactation
- age ≤18 years or ≥55 years
- hypertension
- known chronic systemic diseases (i.e., diabetes mellitus, rheumatoid arthritis), - - known hypersensitivity to one of the ingredients of the HA preparation.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Van Yuzuncu Yil University Faculty of Dentistry
Van, 65080
About this study
Official title: Evaluation of Clinical and Biochemical Effects of Hyaluronic Acid on Periodontitis: A Split-mouth Randomized-controlled Trial
Objective: The aim of this study is to evaluate the effect of HA as an adjunct to scaling and root planning (SRP) on clinical parameters, periodontal inflamed surface area (PISA) and adenosine deaminase (ADA), catalase (CAT), and glutathione (GSH) levels in gingival crevicular fluid (GCF) in patients with periodontitis.
Read the detailed description
Design: A total of 24 Stage II-III periodontitis patients will be included in this split-mouth, randomized-controlled study. The study population will be divided into four groups: in Group 1 (SRP): SRP+ saline; in Group 2 (SRP+HAgel): SRP + HA gel; in Group 3 (SRP+HAmo): SRP+ HA mouthrinse; and in Group 4 (SRP+HAmo+HAgel): SRP+HA mouthrinse + HA gingival gel were applied. At baseline and Week 4 periodontal clinical parameters and PISA will be calculated. Also, GCF amount will be collected to evaluate ADA, CAT, and GSH by spectrophotometric analysis.
- Conditions
- Periodontitis
- Being tested
- Scaling and root planning, Hyaluronic acid gel (HA) and SRP, HA mouthrinse and SRP, HA mouthrinse+gel and SRP
- Keywords
- periodontitis, hyaluronic acid, scaling and root planning, adenosione deaminase, catalase, glutathione
- Medical subject headings
- Periodontitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Scaling and root planningProcedure or surgery
Under local anesthesia, full-mouth SRP will be performed by a single investigator. Immediately after the SRP, HA gel or mouthrinse will perform according to the groups' procedure. In Group 1, the periodontal sulcus will be irrigated with saline solution after SRP.
Hyaluronic acid gel (HA) and SRPDrug
Also called HA and SRP
In Group 2, after SRP will be performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA will be applied intrasulcular.
HA mouthrinse and SRPDrug
Also called HAmo+SRP
In Group 3, HA hydrogel mouthrinse will be used as an irrigator after SRP.
HA mouthrinse+gel and SRPDrug
Also called HAmo+HAgel+SRP
In Group 4, after SRP will be performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel will be applied.
| Study group | Role | What they receive |
|---|---|---|
| Scaling and root planning (SRP) | Placebo comparator | Under local anesthesia, full-mouth SRP was performed within 24 h in a single or two sessions using ultrasonic and hand instruments (Gracey, Hu-Friedy, Chicago, IL, USA) by a single investigator (DA). Immediately after the SRP, HA gel (Gengigel, Hyaluronic acid, gingival gel, Ricefarma S.R.L, Italy) or mouthrinse was performed according to the groups' procedure. In Group 1, the periodontal sulcus was irrigated with saline solution after SRP. Receives: Procedure: Scaling and root planning |
| Hyaluronic acid gel (HA) and SRP | Experimental | Group 2, after SRP was performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA was applied intrasulcular. Receives: Procedure: Scaling and root planning; Drug: Hyaluronic acid gel (HA) and SRP |
| HA mouthrinse and SRP | Experimental | In Group 3, HA hydrogel mouthrinse (Gengigel, Hyaluronic acid, Hydrogel moutrinse for gums, Ricefarma S.R.L, Italy) were used as an irrigator after SRP. Receives: Procedure: Scaling and root planning; Drug: HA mouthrinse and SRP |
| HA mouthrinse+gel and SRP | Experimental | In Group 4, after SRP was performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel was applied. Receives: Procedure: Scaling and root planning; Drug: HA mouthrinse+gel and SRP |
What is being measured
The primary outcome is the main question the study is designed to answer.
plaque index
in accordance with the Sillness and Löe index (Silness \& Löe, 1964)
Measured: Change from Baseline to week 4
gingival index (GI)
confirming to Silness and Löe index (Löe \& Silness, 1963)
Measured: Change from Baseline to week 4
bleeding on probing (BOP)
according to Ainoma and Bay (AINAMO \& Bay, 1975);
Measured: Change from Baseline to week 4
Probing depth (PD)
as the measurement of the length between the bottom of the periodontal pocket to marginal gingiva;
Measured: Change from Baseline to week 4
gingival recession height (GRH)
as the measurement of the distance between the marginal gingiva and cemento-enamel junction
Measured: Change from Baseline to week 4
clinical attachment level (CAL)
as the sum of gingival recession height and probing depth will be recorded.
Measured: Change from Baseline to week 4
Secondary outcomes (4)
Changes of Periodontal inflammed surface area
All clinical parameters will be entered on Microsoft Excel Program (www.parsprototo.info) which constructed for calculating PISA. The BOP percentage for each tooth will be calculated by entering "number sites with BOP" values in the Excel program.
Measured: Change from Baseline Baseline to week 4
Changes of Adenosine deaminase (ADA) levels in gingival crevicular fluid
The ADA activity will be evaluated spectrophotometrically
Measured: Changes from Baseline to week 1,2,4
Changes of Catalase levels in gingival crevicular fluid
The catalase activity will be evaluated spectrophotometrically
Measured: Changes from Baseline to week 1,2,4
Changes of Glutathione levels in gingival crevicular fluid
The Glutathione activity will be evaluated spectrophotometrically
Measured: Changes from Baseline to week 1,2,4
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Nov 2018
- Study start30 Aug 2017
- Primary completion30 Apr 2018
- Study completion30 Sep 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PeriodontitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yuzuncu Yil University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hacer Sahin Aydinyurt, Yuzuncu Yil University
- Investigators
- Hacer Sahin Aydinyurt, Assist Prof, Study director, Yuzuncu Yil University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03754010
- Sponsor's protocol ID
- 19.07.2017/09
- Status last verified
- Nov 2018
- First submitted
- 15 Nov 2018
- Last updated
- 27 Nov 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Aydinyurt HS, Akbal D, Altindal D, Bozoglan A, Ertugrul AS, Demir H. Evaluation of biochemical and clinical effects of hyaluronic acid on non-surgical periodontal treatment: a randomized controlled trial. Ir J Med Sci. 2020 Nov;189(4):1485-1494. doi: 10.1007/s11845-020-02230-6. Epub 2020 May 21.
PubMed 32436173
Study at a glance
From the registry record, last updated by the sponsor on 27 Nov 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Clinical and Biochemical Effects of Hyaluronic Acid on Periodontitis: A Split-mouth Randomized-controlled Trial
- ClinicalTrials.gov ID
- NCT03754010
- Acronym / sponsor ID
- 19.07.2017/09
- Conditions
- Periodontitis
- Keywords
- periodontitis, hyaluronic acid, scaling and root planning, adenosione deaminase, catalase, glutathione
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Yuzuncu Yil UniversityUniversity, hospital or other
- Study start
- 30 Aug 2017 (actual)
- Primary completion
- 30 Apr 2018 (actual)
- Study completion
- 30 Sep 2018 (actual)
- First posted
- 27 Nov 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: The aim of this study is to evaluate the effect of HA as an adjunct to scaling and root planning (SRP) on clinical parameters, periodontal inflamed surface area (PISA) and adenosine deaminase (ADA), catalase (CAT), and glutathione (GSH) levels in gingival crevicular fluid (GCF) in patients with periodontitis.
Detailed description
Design: A total of 24 Stage II-III periodontitis patients will be included in this split-mouth, randomized-controlled study. The study population will be divided into four groups: in Group 1 (SRP): SRP+ saline; in Group 2 (SRP+HAgel): SRP + HA gel; in Group 3 (SRP+HAmo): SRP+ HA mouthrinse; and in Group 4 (SRP+HAmo+HAgel): SRP+HA mouthrinse + HA gingival gel were applied. At baseline and Week 4 periodontal clinical parameters and PISA will be calculated. Also, GCF amount will be collected to evaluate ADA, CAT, and GSH by spectrophotometric analysis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Scaling and root planning (SRP) | Placebo comparator | Procedure: Scaling and root planningUnder local anesthesia, full-mouth SRP was performed within 24 h in a single or two sessions using ultrasonic and hand instruments (Gracey, Hu-Friedy, Chicago, IL, USA) by a single investigator (DA). Immediately after the SRP, HA gel (Gengigel, Hyaluronic acid, gingival gel, Ricefarma S.R.L, Italy) or mouthrinse was performed according to the groups' procedure. In Group 1, the periodontal sulcus was irrigated with saline solution after SRP. |
| Hyaluronic acid gel (HA) and SRP | Experimental | Procedure: Scaling and root planning, Drug: Hyaluronic acid gel (HA) and SRPGroup 2, after SRP was performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA was applied intrasulcular. |
| HA mouthrinse and SRP | Experimental | Procedure: Scaling and root planning, Drug: HA mouthrinse and SRPIn Group 3, HA hydrogel mouthrinse (Gengigel, Hyaluronic acid, Hydrogel moutrinse for gums, Ricefarma S.R.L, Italy) were used as an irrigator after SRP. |
| HA mouthrinse+gel and SRP | Experimental | Procedure: Scaling and root planning, Drug: HA mouthrinse+gel and SRPIn Group 4, after SRP was performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel was applied. |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Systemically healthy
- moderate-to-severe periodontitis
- at least five sites with ≥5mm probing depth (PD)
- at least ≥20 teeth
- Stage II-III periodontitis according to the 2017 World Workshop
Key exclusion criteria (8 listed)
- receiving systemic or local antibiotics within the past six months
- prior surgical or non-surgical periodontal treatment within the past six months
- smoking
- pregnancy
- lactation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Scaling and root planningUnder local anesthesia, full-mouth SRP will be performed by a single investigator. Immediately after the SRP, HA gel or mouthrinse will perform according to the groups' procedure. In Group 1, the periodontal sulcus will be irrigated with saline solution after SRP. | Procedure or surgery | HA mouthrinse and SRP, HA mouthrinse+gel and SRP, Hyaluronic acid gel (HA) and SRP, Scaling and root planning (SRP) |
| Hyaluronic acid gel (HA) and SRPAlso: HA and SRPIn Group 2, after SRP will be performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA will be applied intrasulcular. | Drug | Hyaluronic acid gel (HA) and SRP |
| HA mouthrinse and SRPAlso: HAmo+SRPIn Group 3, HA hydrogel mouthrinse will be used as an irrigator after SRP. | Drug | HA mouthrinse and SRP |
| HA mouthrinse+gel and SRPAlso: HAmo+HAgel+SRPIn Group 4, after SRP will be performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel will be applied. | Drug | HA mouthrinse+gel and SRP |
Primary outcome
plaque index
Time frame: Change from Baseline to week 4
in accordance with the Sillness and Löe index (Silness \& Löe, 1964)
gingival index (GI)
Time frame: Change from Baseline to week 4
confirming to Silness and Löe index (Löe \& Silness, 1963)
bleeding on probing (BOP)
Time frame: Change from Baseline to week 4
according to Ainoma and Bay (AINAMO \& Bay, 1975);
Probing depth (PD)
Time frame: Change from Baseline to week 4
as the measurement of the length between the bottom of the periodontal pocket to marginal gingiva;
gingival recession height (GRH)
Time frame: Change from Baseline to week 4
as the measurement of the distance between the marginal gingiva and cemento-enamel junction
clinical attachment level (CAL)
Time frame: Change from Baseline to week 4
as the sum of gingival recession height and probing depth will be recorded.
4 secondary outcomes
Changes of Periodontal inflammed surface area
Time frame: Change from Baseline Baseline to week 4
Changes of Adenosine deaminase (ADA) levels in gingival crevicular fluid
Time frame: Changes from Baseline to week 1,2,4
Changes of Catalase levels in gingival crevicular fluid
Time frame: Changes from Baseline to week 1,2,4
Changes of Glutathione levels in gingival crevicular fluid
Time frame: Changes from Baseline to week 1,2,4
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Nov 2018.
- Derived from this study: PubMed 32436173Aydinyurt HS, Akbal D, Altindal D, Bozoglan A, Ertugrul AS, Demir H. Evaluation of biochemical and clinical effects of hyaluronic acid on non-surgical periodontal treatment: a randomized controlled trial. Ir J Med Sci. 2020 Nov;189(4):1485-1494. doi: 10.1007/s11845-020-02230-6. Epub 2020 May 21.
Related trials for Periodontitis
RecruitingObservational study
Characterization of Small Intestinal Bacterial Overgrowth and Intestinal Barrier-Related Biomarkers in Patients With Severe Periodontitis
Periodontitis (Stage 3), Periodontitis Stage IV
RecruitingObservational study
Candida Albicans in Syrian Patients With Periodontitis
Periodontal Disease, Periodontal Diseases
Not yet recruiting
Influence of Continuous Rotation Versus Reciprocation Motion of MG3 Blue Rotary File on Postoperative Pain and Intracanal Bacterial Reduction of Teeth With Necrotic Pulps.
Necrotic Pulps With no Apical Periodontitis
Not yet recruiting
Clinical and Inflammatory Outcomes of Regenerative Endodontic Treatment Using Injectable Platelet-Rich Fibrin in Mature Necrotic Teeth With Chronic Apical Periodontitis.
Chronic Apical Periodontitis, Pulp Necrosis
Active, not recruiting
Early Healing of Apical Periodontitis After Root Canal Treatment With Bioceramic and Calcium Hydroxide Medicaments: Evaluation Using PAI and ImageJ
Apical Periodontitis, Root Canal Treatment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hacer Sahin Aydinyurt, Assist Prof study director
Yuzuncu Yil University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing Scaling and root planning, Hyaluronic acid gel (HA) and SRP and HA mouthrinse and SRP in people with Periodontitis, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
plaque index (time frame: Change from Baseline to week 4). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03754010, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2018.